Analyst Price Target is $118.00
▲ +8.11% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is $118.00, with a high forecast of $150.00 and a low forecast of $100.00. The average price target represents a 8.11% upside from the last price of $109.15.
Current Consensus is
The current consensus among 6 investment analysts is to hold stock in Twist Bioscience. This rating has held steady since January 2021, when it changed from a Buy consensus rating.
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.